ATE344050T1 - Verwendung von tcf-ii zur behandlung von durch krebs verursachtem gewichtsverlust, anaemie und tnf-erhöhung - Google Patents
Verwendung von tcf-ii zur behandlung von durch krebs verursachtem gewichtsverlust, anaemie und tnf-erhöhungInfo
- Publication number
- ATE344050T1 ATE344050T1 AT98907159T AT98907159T ATE344050T1 AT E344050 T1 ATE344050 T1 AT E344050T1 AT 98907159 T AT98907159 T AT 98907159T AT 98907159 T AT98907159 T AT 98907159T AT E344050 T1 ATE344050 T1 AT E344050T1
- Authority
- AT
- Austria
- Prior art keywords
- tcf
- cancer
- anaemia
- tnf
- elevation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1833—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Nutrition Science (AREA)
- Obesity (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines Containing Plant Substances (AREA)
- Compounds Of Unknown Constitution (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8216297 | 1997-03-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE344050T1 true ATE344050T1 (de) | 2006-11-15 |
Family
ID=13766743
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT98907159T ATE344050T1 (de) | 1997-03-14 | 1998-03-11 | Verwendung von tcf-ii zur behandlung von durch krebs verursachtem gewichtsverlust, anaemie und tnf-erhöhung |
Country Status (10)
Country | Link |
---|---|
US (4) | US20020041863A1 (de) |
EP (1) | EP0950416B1 (de) |
AT (1) | ATE344050T1 (de) |
AU (1) | AU734766B2 (de) |
CA (1) | CA2253629A1 (de) |
DE (1) | DE69836315T2 (de) |
DK (1) | DK0950416T3 (de) |
ES (1) | ES2274567T3 (de) |
WO (1) | WO1998041230A1 (de) |
ZA (1) | ZA982068B (de) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4006058B2 (ja) | 1997-03-11 | 2007-11-14 | 第一三共株式会社 | 多臓器不全予防及び/又は治療剤 |
ZA982068B (en) | 1997-03-14 | 1998-09-16 | Snow Brand Milk Products Co Ltd | Agent for preventing and/or treating cachexia |
JPH1129493A (ja) * | 1997-07-14 | 1999-02-02 | Snow Brand Milk Prod Co Ltd | 放射線障害予防及び/又は治療剤 |
CA2677452A1 (en) * | 2007-02-14 | 2008-08-21 | Karolinska Innovations Ab | Compositions for increasing body weight, use and methods |
CA2699854A1 (en) * | 2007-09-17 | 2009-03-26 | Bioneris Ab | Use of compounds comprising phosphorous for the treatment of cachexia |
EP2221043A1 (de) | 2009-02-21 | 2010-08-25 | Bayer MaterialScience AG | Haarfestiger-Zusammensetzung |
TW201333870A (zh) | 2011-12-21 | 2013-08-16 | 艾登工具股份有限公司 | 決定病人胰島素療法的系統及方法 |
US20220047643A1 (en) * | 2019-01-17 | 2022-02-17 | Figene, Llc | Fibroblasts and microvesicles thereof for reduction of toxicity associated with cancer immunotherapy |
Family Cites Families (74)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US604185A (en) * | 1898-05-17 | Submarine boat | ||
US498680A (en) * | 1893-05-30 | Boat for transporting railroad-cars | ||
US539590A (en) * | 1895-05-21 | passoni | ||
US604184A (en) * | 1898-05-17 | Oil-can | ||
US462277A (en) * | 1891-11-03 | Or reducing mill | ||
US587311A (en) * | 1897-08-03 | Regulating admission of currents to motors | ||
US950416A (en) * | 1910-02-22 | Albert Sutton | Wheel-tire. | |
US653211A (en) * | 1900-04-03 | 1900-07-10 | John H Calkins | Box for spool goods. |
US757994A (en) * | 1903-04-09 | 1904-04-19 | Oliver Chilled Plow Works | Sulky lister-plow. |
US914829A (en) * | 1908-08-26 | 1909-03-09 | Albert O Hanson | Can-opener. |
US2116192A (en) * | 1936-03-26 | 1938-05-03 | Draminsky Per | Elastic coupling |
US2100720A (en) * | 1937-01-11 | 1937-11-30 | Shaw Walker Co | Letter tray |
US3904753A (en) | 1970-02-20 | 1975-09-09 | Research Corp | Clinically active bovine growth hormone fraction |
US4076701A (en) | 1975-07-29 | 1978-02-28 | Immunology Research Foundation, Inc. | Tumor complement fraction recovery method and product |
US4490549A (en) | 1977-04-19 | 1984-12-25 | The Upjohn Company | Enlarged-hetero-ring prostacyclin analogs |
US4481137A (en) | 1982-02-26 | 1984-11-06 | Mochida Pharmaceutical Co., Ltd. | Glycoproteins and processes for their production |
JPS60112718A (ja) | 1983-11-21 | 1985-06-19 | Kyorin Pharmaceut Co Ltd | 抗腫瘍作用を示す蛋白性物質及びその製造方法 |
US4650674A (en) | 1984-07-05 | 1987-03-17 | Genentech, Inc. | Synergistic cytotoxic composition |
US4870163A (en) | 1985-08-29 | 1989-09-26 | New York Blood Center, Inc. | Preparation of pure human tumor necrosis factor and hybridomas producing monoclonal antibodies to human tumor necrosis factor |
US5326716A (en) * | 1986-02-11 | 1994-07-05 | Max Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V. | Liquid phase epitaxial process for producing three-dimensional semiconductor structures by liquid phase expitaxy |
US4822605A (en) | 1986-02-18 | 1989-04-18 | Exovir, Inc. | Compositions and methods employing the same for the treatment of viral and cancerous skin lesions and the like |
JPS6429951A (en) | 1987-07-24 | 1989-01-31 | Hitachi Ltd | Storage system |
JPS6468400A (en) | 1987-09-09 | 1989-03-14 | Sapporo Breweries | Human tumor cytotoxic factor htcf, production thereof and antitumor agent comprising said factor as active ingredient |
KR890009412A (ko) | 1987-12-22 | 1989-08-01 | 마쓰시따 렌조오 | 종양 세포 억제 인자 |
JPH0296598A (ja) | 1988-10-03 | 1990-04-09 | Sapporo Breweries Ltd | リンフォカイン活性化キラー細胞誘導抑制因子laksf,その製造法およびそれを有効成分とする免疫抑制剤 |
NZ232813A (en) | 1989-03-10 | 1992-08-26 | Snow Brand Milk Products Co Ltd | Human fibroblast glycoprotein, cell differentiation, blood vessel endothelial cell growth factor, cellular immunology inforcing factor of 78 or 74 thousand daltons plus or minus two thousand daltons |
US5035887A (en) | 1989-09-07 | 1991-07-30 | Institute Of Moelcular Biology, Inc. | Wound healing composition of IL-1 and PDGF or IGF-1 |
US5362716A (en) | 1989-12-27 | 1994-11-08 | The United States Of America As Represented By The Department Of Health And Human Services | Methods for stimulating hematopoietic progenitors using hepatocyte growth factor and lymphokines |
US5648273A (en) | 1989-12-27 | 1997-07-15 | The United States Of America, As Represented By The Department Of Health And Human Services | Hepatic growth factor receptor is the MET proto-oncogene |
JP2784455B2 (ja) | 1990-05-09 | 1998-08-06 | 敏一 中村 | 肝硬変治療剤 |
DE69133492T2 (de) | 1990-06-11 | 2006-08-10 | Nakamura, Toshikazu | Rekombinanter menschlicher Hepatozytwachstumsfaktor und Verfahren zu seiner Herstellung |
JP2750372B2 (ja) | 1990-06-19 | 1998-05-13 | 敏一 中村 | 賢疾患治療剤 |
ATE178354T1 (de) | 1990-07-13 | 1999-04-15 | Snow Brand Milk Products Co Ltd | Plasmid das für die aminosäuresequenz von tcf-ii kodierende dns enthalt, transformierte zelle und produktion einer physiologisch aktiven substanz mit ihrer verwendung |
US5821223A (en) | 1990-09-14 | 1998-10-13 | The United States Of America As Represented By The Department Of Health And Human Services | Method of stimulating cell growth with a novel broad spectrum human lung fibroblast-derived mitogen |
RU2120447C1 (ru) | 1991-02-08 | 1998-10-20 | Санкио Компани Лимитед | ПРОИЗВОДНЫЕ β АМИНО α ГИДРОКСИКАРБОНОВЫХ КИСЛОТ ИЛИ ИХ ФАРМАЦЕВТИЧЕСКИ ПРИЕМЛЕМЫХ СОЛЕЙ ИЛИ ЭФИРОВ, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ |
JPH0597A (ja) | 1991-06-21 | 1993-01-08 | Snow Brand Milk Prod Co Ltd | 新規抗tcf−iiモノクローナル抗体及びそれを用いるtcf−iiの測定方法 |
JP3394982B2 (ja) | 1991-11-07 | 2003-04-07 | 敏一 中村 | ガン療法用副作用防止剤 |
WO1993013066A1 (en) | 1991-12-20 | 1993-07-08 | Syntex (U.S.A.) Inc. | Cyclic amides of 3-amino-2-hydroxy-carboxylic acids as hiv-protease inhibitors |
JP3123617B2 (ja) | 1992-03-04 | 2001-01-15 | 雪印乳業株式会社 | シアル酸結合を有する化合物の製造法 |
NO178729C (no) | 1992-03-31 | 1996-05-22 | Daiichi Seiyaku Co | Terapeutisk aktive sukkerderivater |
US5315000A (en) | 1992-05-14 | 1994-05-24 | Children's Hospital Medical Center | Gene encoding for a L5/3 growth factor and its CDNA |
DE69332221T2 (de) | 1992-05-18 | 2003-04-17 | Genentech, Inc. | Hepatozytwachstumfaktor Variante |
JPH0656692A (ja) | 1992-08-10 | 1994-03-01 | Snow Brand Milk Prod Co Ltd | Tcf−iiを有効成分とする創傷治療剤 |
ES2110057T3 (es) | 1992-07-16 | 1998-02-01 | Snow Brand Milk Products Co Ltd | Composicion medicinal que contiene tcf-ii. |
JP3619526B2 (ja) | 1992-07-16 | 2005-02-09 | 第一製薬株式会社 | Tcf−iiを有効成分とする肝臓疾患治療剤 |
JP3380573B2 (ja) | 1992-07-16 | 2003-02-24 | 第一製薬株式会社 | Tcf−iiを有効成分とする蛋白合成促進剤 |
DE69330960T2 (de) | 1992-07-16 | 2002-04-11 | Snow Brand Milk Products Co., Ltd. | Normalisierer der blutkoagulation enthaltend tcf-ii als aktiven bestandteil |
JP3697460B2 (ja) | 1992-07-17 | 2005-09-21 | 敏一 中村 | Hgf含有製剤 |
AU662434B2 (en) | 1992-08-07 | 1995-08-31 | Sankyo Company Limited | Peptides capable of inhibiting the activity of HIV protease, their preparation and their use |
JP3402476B2 (ja) | 1992-08-24 | 2003-05-06 | 生化学工業株式会社 | リポ多糖結合性タンパク質及びその製造法 |
WO1994006456A1 (en) | 1992-09-16 | 1994-03-31 | Genentech, Inc. | Protection against liver damage by hgf |
US5703047A (en) | 1992-09-21 | 1997-12-30 | Board Of Regents, The University Of Texas System | Methods and treatments for corneal healing with growth factors |
US5589451A (en) | 1992-09-21 | 1996-12-31 | Board Of Regents, The University Of Texas System | Methods and treaments for corneal healing with hepatocyte and keratinocyte growth factors |
JPH06116299A (ja) | 1992-10-02 | 1994-04-26 | Snow Brand Milk Prod Co Ltd | 特定の糖鎖構造により高い生物活性を有する遺伝子組換え型tcf |
MX9308016A (es) | 1992-12-22 | 1994-08-31 | Lilly Co Eli | Compuestos inhibidores de la proteasa del virus de la inmunodeficiencia humana, procedimiento para su preparacion y formulacion farmaceutica que los contiene. |
US5554653A (en) | 1992-12-22 | 1996-09-10 | Eli Lilly And Company | Inhibitors of HIV protease useful for the treatment of AIDS |
EP0628055A1 (de) | 1992-12-28 | 1994-12-14 | Snow Brand Milk Products Co. Ltd. | Modifizierter tcf |
JP3552240B2 (ja) | 1993-02-23 | 2004-08-11 | 第一製薬株式会社 | 高濃度tcf製剤 |
JP3962097B2 (ja) | 1994-03-18 | 2007-08-22 | 敏一 中村 | 免疫抑制剤による副作用の軽減剤 |
JPH07258298A (ja) | 1994-03-18 | 1995-10-09 | Snow Brand Milk Prod Co Ltd | モノクローナル抗体 |
US5707624A (en) | 1994-06-03 | 1998-01-13 | The Regents Of The University Of Michigan | Treatment of Kaposi's sarcoma by inhibition of scatter factor |
ATE248913T1 (de) | 1994-12-27 | 2003-09-15 | Daiichi Seiyaku Co | Tcf mutante |
NZ298141A (en) | 1994-12-27 | 2000-12-22 | Snow Brand Milk Products Co Ltd | Treating lipid metabolism disorder using TCF-II |
JPH08231418A (ja) | 1995-02-24 | 1996-09-10 | Mitsubishi Chem Corp | 腸疾患治療剤 |
AU4953796A (en) | 1995-03-15 | 1996-10-02 | Sanyko Company, Limited | Dipeptide compounds having ahpba structure |
CA2218864A1 (en) | 1995-04-21 | 1996-10-24 | Tsutomu Yonehana | Agent for preventing and/or treating ischemic diseases |
JPH10194986A (ja) | 1996-06-10 | 1998-07-28 | Snow Brand Milk Prod Co Ltd | 移植肝機能改善・再生促進剤 |
JP3887435B2 (ja) | 1996-07-12 | 2007-02-28 | 第一製薬株式会社 | スフェロイド形成促進剤 |
JPH1068400A (ja) | 1996-08-28 | 1998-03-10 | Tetsuo Taira | 液体を押し出すボトルポンプ及びその方法と製造方法 |
JP4006058B2 (ja) | 1997-03-11 | 2007-11-14 | 第一三共株式会社 | 多臓器不全予防及び/又は治療剤 |
ZA982068B (en) | 1997-03-14 | 1998-09-16 | Snow Brand Milk Products Co Ltd | Agent for preventing and/or treating cachexia |
JP3961064B2 (ja) | 1997-03-28 | 2007-08-15 | 第一製薬株式会社 | 腎疾患予防及び/又は治療剤 |
JPH1129493A (ja) | 1997-07-14 | 1999-02-02 | Snow Brand Milk Prod Co Ltd | 放射線障害予防及び/又は治療剤 |
JPH11269091A (ja) | 1998-03-19 | 1999-10-05 | Snow Brand Milk Prod Co Ltd | 敗血症予防及び/又は治療剤 |
-
1998
- 1998-03-11 ZA ZA982068A patent/ZA982068B/xx unknown
- 1998-03-11 AT AT98907159T patent/ATE344050T1/de not_active IP Right Cessation
- 1998-03-11 ES ES98907159T patent/ES2274567T3/es not_active Expired - Lifetime
- 1998-03-11 US US09/180,586 patent/US20020041863A1/en not_active Abandoned
- 1998-03-11 EP EP98907159A patent/EP0950416B1/de not_active Expired - Lifetime
- 1998-03-11 CA CA002253629A patent/CA2253629A1/en not_active Abandoned
- 1998-03-11 AU AU63093/98A patent/AU734766B2/en not_active Ceased
- 1998-03-11 DK DK98907159T patent/DK0950416T3/da active
- 1998-03-11 DE DE69836315T patent/DE69836315T2/de not_active Expired - Fee Related
- 1998-03-11 WO PCT/JP1998/000999 patent/WO1998041230A1/ja active IP Right Grant
-
2002
- 2002-10-09 US US10/267,906 patent/US7115568B2/en not_active Expired - Fee Related
-
2003
- 2003-03-05 US US10/382,103 patent/US7138372B2/en not_active Expired - Fee Related
-
2006
- 2006-05-02 US US11/416,239 patent/US20060193827A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
DK0950416T3 (da) | 2007-02-26 |
DE69836315T2 (de) | 2007-05-31 |
US20030082134A1 (en) | 2003-05-01 |
EP0950416B1 (de) | 2006-11-02 |
US7115568B2 (en) | 2006-10-03 |
EP0950416A1 (de) | 1999-10-20 |
AU6309398A (en) | 1998-10-12 |
DE69836315D1 (de) | 2006-12-14 |
WO1998041230A1 (fr) | 1998-09-24 |
EP0950416A4 (de) | 2004-06-16 |
CA2253629A1 (en) | 1998-09-24 |
ZA982068B (en) | 1998-09-16 |
AU734766B2 (en) | 2001-06-21 |
US20020041863A1 (en) | 2002-04-11 |
ES2274567T3 (es) | 2007-05-16 |
US7138372B2 (en) | 2006-11-21 |
US20060193827A1 (en) | 2006-08-31 |
US20030236191A1 (en) | 2003-12-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE499934T1 (de) | Verwendung von (3.2.0) heterocyclischen verbindungen und ihren analoga zur behandlung von krebs | |
DE69108048D1 (de) | Derivate von hydroxaminsäure und von n-hydroxyharnstoff sowie ihre verwendung. | |
DK0871439T3 (da) | Substituerede (aryl, heteroaryl, arylmethyl eller heteroarylmethyl) hydroxamsyreforbindelser | |
EA200000723A1 (ru) | Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола | |
ATE317262T1 (de) | Verwendung von tetracyclinderivaten zur steigerung der interleukin-10 produktion | |
DE69627467D1 (de) | Verwendung von zusammensetzungen mit benzoylperoxyd, glycolsäure und zink zur behandlung von dermatologischen krankheiten | |
ID21526A (id) | 4-hidroksiquinolin-3-karboksamida dan hidrazida sebagai bahan anti-virus | |
WO2003105757A3 (en) | METHODS AND COMPOSITIONS FOR MEDIA-DEPENDENT BINDING OF A TARGET AGENT TO A TARGET | |
ATE238792T1 (de) | Verwendung von makroliden zur behandlung von glaukom | |
DE3484395D1 (de) | Laser zur medizinischen behandlung kranker bereiche organischen gewebes. | |
DE69930271T8 (de) | Medizinische zusammensetzungen zur behandlung von augenerkrankungen | |
DE69607615D1 (de) | Neuartige metalloprotease-inhibitoren und diese enthaltende pharmazeutische zusammensetzungen | |
ATE344050T1 (de) | Verwendung von tcf-ii zur behandlung von durch krebs verursachtem gewichtsverlust, anaemie und tnf-erhöhung | |
ES2090081T3 (es) | Derivados de indolocarbazol, procedimientos para su obtencion y su empleo. | |
BR0213417A (pt) | Compostos e composições de tetraciclicazaindóis e indolinas tendo atividade de 5-ht e seus usos | |
EE9900450A (et) | Tetrahüdropüridoühendid, neid sisaldav ravim ja nende kasutamine | |
DE59710517D1 (de) | Adamantanaminenderivate zur bekämpfung von viren der familie bornaviridae | |
BR0210401A (pt) | Composto, composição farmacêutica, uso de um composto e método para o tratamento de um distúrbio ou de uma doença de um corpo de animal vivo, incluindo um humano | |
DE60018704D1 (de) | Bretyliumhaltige zusammensetzungen und kits und deren verwendung zur vorbeugung und behandlung cardiovaskulärer erkrankungen | |
ATE517626T1 (de) | Aminosubstituierte sulphonanilide und ihre derivate zur behandlung von proliferativen erkrankungen | |
ATE316379T1 (de) | Oxyhuminsäure und ihre verwendung zur behandlung von verschiedenenen störungen | |
DK0821969T3 (da) | Medicinsk sammensætning omfattende TCF-II | |
ATE185274T1 (de) | Therapeutisches mittel gegen drohenden abortus | |
RU95110774A (ru) | Олигонуклеотиды, терапевтические композиции, применение композиций | |
DE69103773D1 (de) | Derivate von hydroxaminsäure die lipoxygenase hemmen. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 0950416 Country of ref document: EP |
|
EEIH | Change in the person of patent owner | ||
REN | Ceased due to non-payment of the annual fee |